Global Hepatitis B and C Diagnostics Market 2016-2020

Publisher Name :
Date: 30-Aug-2016
No. of pages: 110
Inquire Before Buying

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

The analysts forecast global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Abbott Diagnostics

  • Roche Diagnostics

  • Siemens Healthcare

  • QIAGEN


Other prominent vendors


  • Affymetrix

  • Allele Biotechnology

  • Axis-Shield

  • Becton Dickinson

  • bioMérieux

  • Cepheid

  • Chembio Diagnostics

  • DiaMetra

  • DiaSorin

  • Enzo Life Sciences

  • Hologic

  • ImmunoDX

  • MedMira

  • OraSure Technologies

  • Quest Diagnostics

  • Quidel

  • Randox Laboratories

  • Vela Diagnostics

  • Vital Diagnostics

  • ZEUS Scientific


Market driver


  • Strategies of healthcare organizations toward simplifying the diagnostic process

  • For a full, detailed list, view our report


Market challenge


  • Regulatory and reimbursement hurdles limit the adoption rate

  • For a full, detailed list, view our report


Market trend


  • Advent of immunosensors in the HBV and HCV diagnostic tests

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2020 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Global Hepatitis B and C Diagnostics Market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights
Hepatitis B and C diagnostics: An overview
Hepatitis B disease overview
Hepatitis C disease overview

PART 05: Reimbursement scenario: An overview

PART 06: Market landscape
Market overview
Global hepatitis B and C diagnostics market overview
Five forces analysis

PART 07: Market segmentation by procedure
Immunodiagnostics
Immunofluorescence
Instruments
Reagents
Global hepatitis B and C immunodiagnostics market overview
NAT
Global hepatitis B and C NAT market overview

PART 08: Market segmentation by disease
Hepatitis B
Global hepatitis B diagnostics market overview
Hepatitis C
Global hepatitis C diagnostics market overview

PART 09: Geographical segmentation
Hepatitis B and C diagnostics market in Americas
Hepatitis B and C diagnostics market in EMEA
Hepatitis B and C diagnostics market in APAC

PART 10: Market drivers
Growing demand for molecular diagnostics in the diagnosis of HBV and HCV
Strategies of healthcare organizations toward simplifying the diagnostic process
Rising demand for POC diagnostics
Increase in demand for automation and system integration

PART 11: Impact of drivers

PART 12: Market challenges
Presence of high undiagnosed individuals
Limited detection capability and complexity of assays
Regulatory and reimbursement hurdles limit the adoption rate
Limitations of closed systems

PART 13: Impact of drivers and challenges

PART 14: Market trends
Advent of immunosensors in the HBV and HCV diagnostic tests
Paradigm shift toward the use of hepatitis C core antigen test
High demand for biomarker-based tests

PART 15: Vendor landscape
Competitive scenario
Key news

PART 16: Key vendor analysis
Abbott Diagnostics
Roche Diagnostics
Siemens Healthcare
QIAGEN
Other prominent vendors

PART 17: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Possible outcomes of HBV infection
Exhibit 03: Concentration of HBV in several body fluids
Exhibit 04: Pathway of hepatitis B progression
Exhibit 05: Disease progression of hepatitis B
Exhibit 06: Significance of serological markers
Exhibit 07: Types of hepatitis B diagnostic tests
Exhibit 08: Diagnostic strategies for HBV
Exhibit 09: Interpretation of serological markers
Exhibit 10: Endemicity pattern of hepatitis B across different regions
Exhibit 11: Medical cost for chronic viral hepatitis
Exhibit 12: Progression of hepatitis C
Exhibit 13: Risk factors for hepatitis transmission
Exhibit 14: Screening tests for hepatitis C infection
Exhibit 15: Medical cost for hepatitis C and related infections
Exhibit 16: Reimbursement perspectives of healthcare entities
Exhibit 17: Global hepatitis B and C diagnostics market analysis: Developed and emerging markets
Exhibit 18: Snapshot of global hepatitis B and C diagnostics market
Exhibit 19: Global hepatitis B and C diagnostics market 2025-2020 ($ billions)
Exhibit 20: Opportunity analysis of hepatitis B and C diagnostics market
Exhibit 21: Five forces analysis
Exhibit 22: Global hepatitis B and C diagnostics market by procedure 2015-2020
Exhibit 23: Global hepatitis B and C diagnostics market by procedure 2015 ($ billions)
Exhibit 24: Global hepatitis B and C diagnostics market by procedure: Lifecycle analysis 2015
Exhibit 25: Global hepatitis B and C immunodiagnostics market 2025-2020 ($ billions)
Exhibit 26: Opportunity analysis of immunodiagnostics
Exhibit 27: Global hepatitis B and C immunodiagnostics market segmentation by product type 2015
Exhibit 28: Global hepatitis B and C NAT market 2025-2020 ($ millions)
Exhibit 29: Global hepatitis B and C NAT market segmentation by product type 2015
Exhibit 30: Opportunity analysis of global hepatitis B and C NAT market
Exhibit 31: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 ($ millions)
Exhibit 32: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 (%)
Exhibit 33: Global hepatitis B and C diagnostics market segmentation: Impact analysis 2015-2020
Exhibit 34: Global hepatitis B and C diagnostics market by disease type 2015-2020
Exhibit 35: Global hepatitis B and C diagnostics market by disease type 2015
Exhibit 36: Global hepatitis B and C diagnostics market by disease type: Lifecycle analysis 2015
Exhibit 37: Acute hepatitis B infection by demography 2015
Exhibit 38: Chronic hepatitis B infection by demography 2015
Exhibit 39: Procurement of hepatitis B diagnostic kits by WHO 2015
Exhibit 40: Global hepatitis B diagnostics market 2015-2020 ($ millions)
Exhibit 41: Opportunity analysis of global hepatitis B diagnostics market
Exhibit 42: Prevalence rates of hepatitis C across different regions 2015
Exhibit 43: Treatment cost of hepatitis C-related infections
Exhibit 44: Procurement of hepatitis C diagnostic kits by WHO 2015
Exhibit 45: Opportunity analysis of hepatitis C
Exhibit 46: Global hepatitis C diagnostics market 2015-2020 ($ billions)
Exhibit 47: Global hepatitis B and C diagnostics market by disease type 2015-2020 ($ millions)
Exhibit 48: Global hepatitis B and C diagnostics market by disease type 2015-2020 (%)
Exhibit 49: Global hepatitis B and C diagnostics segmentation by disease type
Exhibit 51: Geographical hepatitis B and C diagnostics market 2015
Exhibit 52: Global hepatitis B and C diagnostics: Regional market lifecycle analysis
Exhibit 53: Global hepatitis B and C diagnostics market by geography 2015-2020
Exhibit 54: Global hepatitis and C diagnostics market segmentation by geography 2015
Exhibit 55: Global hepatitis B and C diagnostics market by geography lifecycle analysis 2015
Exhibit 56: Hepatitis B and C diagnostics in Americas 2015
Exhibit 57: Prevalence data of hepatitis C in North America
Exhibit 58: Prevalence data of hepatitis C in Latin America
Exhibit 59: Hepatitis B and C diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 60: Prevalence data of hepatitis C in Europe
Exhibit 61: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 62: Prevalence rate of hepatitis B in APAC
Exhibit 63: Prevalence data of hepatitis C in APAC
Exhibit 64: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 65: Global hepatitis B and C diagnostics market by geography 2025-2020 ($ millions)
Exhibit 66: Global hepatitis B and C diagnostics market by geography 2025-2020 (%)
Exhibit 67: Global hepatitis B and C diagnostics market by geography
Exhibit 68: Strategies of healthcare organizations
Exhibit 69: Advantages of POC diagnostics
Exhibit 70: Recent and expected product launches of HCV POC diagnostic tests
Exhibit 71: Impact of drivers
Exhibit 72: Prevalence and diagnosis of HCV infections across developing countries 2015 (millions)
Exhibit 73: Key factors affecting the adoption rates
Exhibit 74: Force field analysis of global hepatitis b and C diagnostics market
Exhibit 75: Impact of drivers and challenges
Exhibit 76: Key advantages driving the adoption of HCV core antigen test
Exhibit 77: Impact of trends on global hepatitis B and C diagnostics market 2015-2020
Exhibit 78: Key leading vendors ranking for instruments 2015
Exhibit 79: Presence of vendors in the global hepatitis B and C diagnostics market
Exhibit 80: Abbott Laboratories: Key business offerings
Exhibit 81: Abbott Diagnostics: Metric analysis
Exhibit 82: Hoffmann-La Roche: Business segmentation by revenue 2015
Exhibit 83: Roche Diagnostics: Products and description
Exhibit 84: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 85: Roche Diagnostics: Metric analysis
Exhibit 86: Siemens Healthcare: Various tests available in multiple diseases
Exhibit 87: Siemens Healthcare: Metric analysis
Exhibit 88: QIAGEN: Metric analysis

  • Global Hepatitis vaccine Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 119
    Notes: Production, means the output of Hepatitis vaccine Revenue, means the sales value of Hepatitis vaccine This report studies Hepatitis vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and mar......
  • Global Human Hepatitis B Immunoglobulin Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 119
    Notes: Production, means the output of Human Hepatitis B Immunoglobulin Revenue, means the sales value of Human Hepatitis B Immunoglobulin This report studies Human Hepatitis B Immunoglobulin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter - CSL - Bayer - Gri......
  • Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 113
    Notes: Production, means the output of Human Hepatitis B Immunoglobulin (IM) Revenue, means the sales value of Human Hepatitis B Immunoglobulin (IM) This report studies Human Hepatitis B Immunoglobulin (IM) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter - CSL - Bay......
  • Global Thymosin Alpha 1 Market Professional Survey Report 2016
    Published: 25-Nov-2016        Price: US 3500 Onwards        Pages: 102
    Notes: Production, means the output of Thymosin Alpha 1 Revenue, means the sales value of Thymosin Alpha 1 This report studies Thymosin Alpha 1 in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market......
  • Telavic -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Telavic- Drug Insights, 2016" highlights the Telavic marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Telavic covering the total sales estimation and also provides the Telavic sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Telavic, patents information and exclus......
  • Victrelis -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Victrelis- Drug Insights, 2016" highlights the Victrelis marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Victrelis covering the total sales estimation and also provides the Victrelis sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Victrelis, patents information ......
  • Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, "Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities incl......
  • ViraferonPeg -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "ViraferonPeg- Drug Insights, 2016" highlights the ViraferonPeg marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the ViraferonPeg covering the total sales estimation and also provides the ViraferonPeg sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of ViraferonPeg, paten......
  • Viread -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Viread- Drug Insights, 2016" highlights the Viread marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Viread covering the total sales estimation and also provides the Viread sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Viread, patents information and exclusivity......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs